NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Under your scenario, At 2.00 a share, LP, by that time, might walk away with half a billion dollars. This need to extend the trial simply changes the percentage ownership to those gaining from the debt obligations infused into the current situation. By not providing timely blinded updates, the share amount gained by the lender at the end of said obligation is much much higher. I really wonder if they are serious about just providing the blinded data soon if the publication is not forthcoming.

Les, from April 27, 2018.

”It's nearing the end and you have to be even more careful. (Not hearing anything...) it doesn't mean it's not happening. It just means its not ripe. We're under such scrutiny, that until it's really clear and will be undeniable, we have to be really careful about it.”

It just seems the new obligations for reserving rooms with Advent (hello that's Toucan) at the empty arms hotel is just a reason to transfer shares from those with less knowledge, to those with more knowledge. I kind of understood this when it seemed there was a potential proxy battle in the near term, but to set up this arrangement again seems to place getting to results on the backburner.

That quote above from Les would make me believe all this new debt obligation stuff simply changes the percentages of ownership from those on the outside, who are "carefully" not getting public updates on the trial...to those on the inside, that are "carefully" getting updates on the trial.

Just one example. THEY [U]KNOW[/U] THE MEDIAN. Those of us on the outside, bears and longs, have it nailed down to ummm.....between 20 and 30 months -- LOL.

Let's pretend they now know what it is, and they know its above 25. That's an advantage. Would you then start try to obtain shares by giving loans at incredible interest rates that would ultimately result in a massive amount of more shares if you knew, (Not guessed) but knew the median plus much much more?

It seems like despite the vote, and NWBO's thanks, they would like to keep that median to themselves in the form of an unpublished journal.

Each day it goes by unpublished, the price remains low. When the loan becomes due. The lender gets more shares. The "careful" retention of knowledge (only held back by a publishing process -- not the FDA and not the SEC, imo), that is otherwise perfectly willing to be shared, held back by a publication process results in low share value to longs. Forces people to average down or be irrelevant and shifts the balance of ownership even further toward the lender Toucan and LP.

I would have thought they would have been humble after the proxy vote, but they went straight to the empty arms hotel financing structure, and hold over the public this supposed imminent publication data, that does not have to be published by a Journal to be made public.

Let's consider if the publication/data/median was made public knowledge tomorrow. Let's say it is really decent info that makes AVII's 20 mOS look ridiculously small. The price would try to rise, and LP would no longer be the only one willing to finance NWBO or simply buy large on the open market. The transfer of share ownership would be more fairly and publicly distributed and LP might end up with something like 130 million shares in the end instead of close to 200 million. I'm just ball parking those share count numbers.

LP states it is better to release in a formal, high impact publication, but she is considering releasing the blinded data without it. In, perhaps, a "bit."

Meanwhile the transfer of ownership percentage goes on. We are well beyond the time for determining statistical significance. Why continue to keep the price down with a 12 month old secret box of data your otherwise perfectly willing to share? Why "carefully" keep that box shut?

You you get it? It's one thing to guess what's in the blinded publication data, but it's another thing to know and create all these debt structures and hold back the information.